Tin Filter Calcium Scoring
Ultra Low-dose Coronary Artery Calcium Scoring Using Tin Filtration With Dual-source CT
1 other identifier
interventional
149
1 country
1
Brief Summary
The aim of this study is to prospectively investigate the diagnostic performance and potential radiation dose reduction in coronary artery calcium scoring using the new tin filter system of the 3rd generation DSCT scanner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 28, 2016
CompletedFirst Posted
Study publicly available on registry
August 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2017
CompletedAugust 2, 2018
March 1, 2018
2 years
July 28, 2016
July 31, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reduction in radiation dose using the new tin-filter system
2 years
Diagnostic accuracy of novel ultralow-dose non-enhanced coronary artery calcium scoring performed with the new tin filter system.
2 years
Study Arms (1)
Reduction of radiation dose and diagnostic accuracy
EXPERIMENTALReduction of radiation dose during coronary artery calcium scoring with the use of a tin filter system.
Interventions
Eligibility Criteria
You may qualify if:
- Subject must be between 19-90 years of age.
- Subject must have been referred for a clinically indicated coronary artery calcium scan and/or coronary CT angiography or TRO scan with coronary artery calcium scoring.
- Subject must provide written informed consent prior to any study-related procedures being performed.
- Subject must be willing to comply with all clinical study procedures.
You may not qualify if:
- Subject is a pregnant or nursing female. Exclude the possibility of pregnancy:
- By testing (urine BHCG) within 24 hours before scan, or
- By surgical sterilization, or
- Post menopausal, with minimum one (1) year history without menses.
- Subject has an acute psychiatric disorder or is cognitively impaired.
- Subject is using or is dependent on substances of abuse.
- Subject is unwilling to comply with the requirements of the protocol.
- Subject is in acute unstable condition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph U. Schoepf, MD
Medical University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2016
First Posted
August 4, 2016
Study Start
December 1, 2015
Primary Completion
November 14, 2017
Study Completion
November 14, 2017
Last Updated
August 2, 2018
Record last verified: 2018-03